Adjuvant therapy in colon cancer—what, when and how?
作者： I. Chau , D. Cunningham
关键词: Internal medicine 、 Adjuvant therapy 、 Fluorouracil 、 Irinotecan 、 Oxaliplatin 、 Oncology 、 Colorectal cancer 、 Chemotherapy regimen 、 Bevacizumab 、 Cetuximab 、 Medicine
摘要: … of care in adjuvant treatment of stage III colon cancer. The advent of monoclonal antibodies … studies in adjuvant therapy of colon cancer. In stage II colon cancer, adjuvant treatment …
annalsofoncology.org
core.ac.uk
oup.com
oxfordjournals.org
sci-hub.se 参考文章(60)
N. Wolmark, S. Wieand, B. Lembersky, L. Colangelo, R. Smith, R. Pazdur, A phase III trial comparing oral UFT to FULV in stage II and III carcinoma of the colon: Results of NSABP Protocol C-06 Journal of Clinical Oncology. ,vol. 22, pp. 3508- 3508 ,(2004) , 10.1200/JCO.2004.22.90140.3508
B G Taal, , H Van Tinteren, F A N Zoetmulder, Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. British Journal of Cancer. ,vol. 85, pp. 1437- 1443 ,(2001) , 10.1054/BJOC.2001.2117
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer The New England Journal of Medicine. ,vol. 353, pp. 2747- 2757 ,(2005) , 10.1056/NEJMOA052258
Rainer Porschen, Andreas Bermann, Thomas Löffler, Gregor Haack, Klaus Rettig, Yvonne Anger, Georg Strohmeyer, Fluorouracil Plus Leucovorin as Effective Adjuvant Chemotherapy in Curatively Resected Stage III Colon Cancer: Results of the Trial adjCCA-01 Journal of Clinical Oncology. ,vol. 19, pp. 1787- 1794 ,(2001) , 10.1200/JCO.2001.19.6.1787
M J O'Connell, J A Laurie, M Kahn, R J Fitzgibbons, C Erlichman, L Shepherd, C G Moertel, W I Kocha, R Pazdur, H S Wieand, J Rubin, A M Vukov, J H Donohue, J E Krook, A Figueredo, Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. Journal of Clinical Oncology. ,vol. 16, pp. 295- 300 ,(1998) , 10.1200/JCO.1998.16.1.295
Alvaro Figueredo, Manya L. Charette, Jean Maroun, Melissa C. Brouwers, Lisa Zuraw, Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group Journal of Clinical Oncology. ,vol. 22, pp. 3395- 3407 ,(2004) , 10.1200/JCO.2004.03.087
W Schippinger, M Jagoditsch, C Sorre, M Gnant, G Steger, H Hausmaninger, B Mlineritsch, R Schaberl-Moser, HJ Mischinger, F Hofbauer, P Holzberger, M Mittlböck, R Jakesz, None, A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer. British Journal of Cancer. ,vol. 92, pp. 1655- 1662 ,(2005) , 10.1038/SJ.BJC.6602555
N. Wolmark, B. Fisher, H. Rockette, C. Redmond, D. L. Wickerham, E. R. Fisher, J. Jones, A. Glass, H. Lerner, W. Lawrence, D. Prager, M. Wexler, J. Evans, A. Cruz, N. Dimitrov, P. Jochimsen, , Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011 JNCI Journal of the National Cancer Institute. ,vol. 80, pp. 30- 36 ,(1988) , 10.1093/JNCI/80.1.30
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 74- 108 ,(2005) , 10.3322/CANJCLIN.55.2.74